PERLE BIOSCIENCE

Perle is setting the stage for usage of a new proprietary peptide therapy for generation of new insulin producing cells, which is a breakthrough with the potential to benefit millions of people.
PERLE BIOSCIENCE
Industry:
Biotechnology Commercial Health Care Industrial Medical
Founded:
2013-05-18
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.perlebioscience.com
Total Employee:
11+
Status:
Active
Contact:
(703) 568-4222
Email Addresses:
[email protected]
Total Funding:
2 M USD
Technology used in webpage:
Content Delivery Network Font Awesome Apache Mobile Non Scaleable Content PHP BootstrapCDN Apache 2.4 CentOS SAKURA Internet
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
March Healthcare Development
March Healthcare Development is a developer of next-generation eHealth applications.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montrรฉal and Lรฉvis.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Founder
Official Site Inspections
http://www.perlebioscience.com
Unable to get host informations!!!

More informations about "Perle Bioscience"
Perle Bioscience - Crunchbase Company Profile & Funding
Perle Bioscience closed its last funding round on Sep 26, 2013 from a Product Crowdfunding round. Who are Perle Bioscience 's competitors? Alternatives and possible competitors to โฆSee details»
Perle Bioscience, Inc. - Drug pipelines, Patents, Clinical trials
May 8, 2025 According to Dr. Claresa Levetan, Founder & Chief Scientific Officer of Perle Bioscience, "For patients with type 1 diabetes, the combination therapy patented by Perle โฆSee details»
Perle Bioscience - PitchBook
Perle Bioscience General Information Description. Provider of medicinal research and development services intended to revolutionize diabetes treatment. The โฆSee details»
Page dโaccueil - Lampes Contemporaines | Minimalisme & Élégance
356 Rue Marcelin Berthelot, 45400 Fleury-les-Aubrais, France. [email protected] Copyright 2025 © Perlebioscience.comSee details»
Perle Bioscience, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Perle Bioscience, Inc. of Sellersville, PA. Get the latest business insights from Dun & Bradstreet.See details»
Perle Bioscience, Inc. Information - RocketReach
Perle Bioscience. Inc. (โPerleโ) has discovered four new human beta regeneration peptides for reversing Type 1 and Type 2 Diabetes. Perle is setting the stage for usage of a new โฆSee details»
Perle Bioscience - 2025 Company Profile - Tracxn
Feb 26, 2025 Perle Bioscience - Peptide therapy for reversing Type 1 and Type 2 Diabetes. This company is not active anymore. Raised a total funding of $4.73M over 2 rounds. Founded by โฆSee details»
Organization | Perle Bioscience, Inc.
Perle Bioscience, Inc. Report issue. For profit Phase 3. Founded: Atlanta GA United States ... Organization Overview. First Clinical Trial. 2014 NCT01762657. First Marketed Drug. None โฆSee details»
Perle Bioscience - Products, Competitors, Financials, Employees ...
Perle Bioscience is engaged in development of new pharmaceutical compositions and methods for reversing Type 1 and 2 Diabetes. Use the CB Insights Platform to explore Perle โฆSee details»
Perle Bioscience, Inc. - Overview, Competitors, And Employees
Perle Bioscience. Inc. (โPerleโ) has discovered four new human beta regeneration peptides for reversing Type 1 and Type 2 Di ... abetes. Perle is setting the stage for usage of a new โฆSee details»
Perle Bioscience Inc Company Profile, Financial and ... - digitGaps
Perle Bioscience, Inc. is a research and development company that engages in finding treatments for type 1 diabetes. Its products include PRL001, which combines the usage of an immune โฆSee details»
PERLE BIOSCIENCE - Perle Bioscience, Inc. Trademark Registration
Owner: Perle Bioscience, Inc. Address: 520 Folly Rd, Suite P-212 Charleston DE 29412: Legal Entity Type: Corporation: Legal Entity State: DESee details»
Perle Bioscience - Funding, Financials, Valuation & Investors
Perle Bioscience is a developer of peptide therapies for the generation of new insulin producing cells.See details»
Perle Bioscience, Inc. | Hatfield PA - Facebook
Perle Bioscience, Inc., Hatfield, Pennsylvania. 5,510 likes. Perle Bioscience has a pipeline of novel therapeutics to regenerate insulin producing cells in the pancreas, thus eliminating the โฆSee details»
Working At Perle Bioscience: Company Overview and Culture
Learn about working at Perle Bioscience from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more. Find out what it's like to work at โฆSee details»
Perle Bioscience - CB Insights
Explore {Perle Bioscience's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Perle Bioscience CEO, โฆSee details»
Perle Bioscience - Crunchbase
Perle Bioscience is a developer of peptide therapies for the generation of new insulin producing cells.See details»
Perle Bioscience - YouTube
Perle Bioscience is a pharmaceutical research and development company dedicated to finding treatments for type 1 diabetes. Clinical Trials are now underway.See details»
Perle Bioscience Soon to Be Ready for Phase III Cinical Trial
Oct 15, 2014 Perle Bioscience and its team of amazing clinicians and researchers is getting ready for Phase III in its clinical trials. They will need newly diagnosed Type 1s for this trial. โฆSee details»
PRL 002 - AdisInsight - Springer
PRL 002 is being developed by Perle Bioscience for the treatment of type 1 and type 2 diabetes mellitus. PRL 002, comprising Beta Regeneration Agent for PRL 002 Next ... If your โฆSee details»